Soft tissue sarcoma

Active Research Protocols

  1. 13-C-0044 – A Phase 2 Study of Cabozantinib (XL184), a Dual Inhibitor of MET and VEGFR, in Patients With Metastatic Refractory Soft Tissue Sarcoma
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014